AzTrials
AzTrials

Cracked NipplePhase 4NCT05591651

Hyaluronic Acid for the Treatment of Damaged Nipples in Breastfeeding Women

A Phase 4 study testing Treatment of damaged nipple skin: Preparation with hyaluronic acid and Treatment of damaged nipple skin: Neutral preparation without hyaluronic acid in people with Cracked Nipple and Breastfeeding, run by Specijalisticka Pedijatrijska Ordinacija prim.mr.sc. Maja Stimac, Specijalist Pedijatrije Sspecijalnosti Neonatologije at 1 site in Croatia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Previous studies have shown that application of hyaluronic acid preparations to wounds of the skin and mucosa have a beneficial effect. There is a lack of studies showing the effect of applying hyaluronic acid preparations to treat damaged nipple skin in breastfeeding mothers. Read more about this study

Who is it for?
Any age, women only
Conditions the study is for
Cracked Nipple, Breastfeeding, Healing Wound
What is being tested?
Treatment of damaged nipple skin: Preparation with hyaluronic acid and Treatment of damaged nipple skin: Neutral preparation without hyaluronic acid
Could I receive a placebo?
No, everyone receives an active treatment
How many people
160 participants
Where
1 siteCroatia
Study dates
9 Jan 2023to Feb 2026
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • for mothers: a breastfeeding mother, living or residing in Osijek, with nipple skin damage (NTS 1, 2, 3, 4, or 5).
  • for babies: newborns from a singleton pregnancy, of gestational age from 37 to 42 weeks, with a birth weight of 2,500 to 4,500 grams.

Who cannot join

  • for mothers: mothers who do not breastfeed, mothers not living or residing in Osijek, mothers without nipple skin damage and mothers using other preparations for healing sore nipples (shells, pads).
  • for children: visible anomalies in the newborn which may affect the breastfeeding process, newborns that required admission to the neonatal unit

Trial locations and contacts

1 site in 1 country.

Maja Štimac, MD; Mr.sc. contact

+385 98 799 188

maja@stimac.org

Croatia1 site, 1 recruiting
  • Savjetovalište za dojenje, Dom zdravlja Osječko-baranjske županije

    Osijek, 31000

    Dragica Pavlović, mag.med.techn., +385 99 815 47 60, dragica.pavlovic@dzobz.hr

    Recruiting

Other trials in Croatia

About this study

Official title: The Effectiveness of Hyaluronic Acid for the Treatment of Damaged Nipples in Breastfeeding Women: a Double-blind Randomised, Controlled Trial

Previous studies have shown that application of hyaluronic acid preparations to wounds of the skin and mucosa have a beneficial effect.

There is a lack of studies showing the effect of applying hyaluronic acid preparations to treat damaged nipple skin in breastfeeding mothers.

This study aims to determine the effect of applying a hyaluronic acid preparation to damaged nipple skin in breastfeeding women.

Read the detailed description

A randomised, controlled, parallel, double-blinded clinical trial will be performed in the Breastfeeding Support Unit of the Health Centre 'Dom zdravlja' in Osijek-Baranja County, Croatia, in 2022.

A randomised controlled study design has been chosen for this trial to compare two ways of treating damaged nipples in breastfeeding women. Participants will be randomly divided into two groups. The randomisation procedure will ensure the reliability of the results. Participants are breastfeeding mothers, with damaged nipples, and their newborn babies. Eligible mothers will be directed to the Breastfeeding Support Unit by the Health Centre's Health Visitors during regular home visits. Participants will be included in the study only if both mother and child meet the inclusion criteria.

Participants will be divided into two groups by simple randomisation: a group receiving a hyaluronic acid preparation and a control group receiving a placebo preparation. Allocation will be performed using a computer-generated list of random numbers. The allocator will know which participant receives which preparation, whereas the main researcher and the participants will not know which preparation is used by any participants. All pregnancy and birth data will be collected from the medical documentation of the mother and the child.

The preparation containing hyaluronic acid and the neutral agent will be prepared in the Galenska laboratory, Ljekarna Srce, Osijek-Baranja County. The hyaluronic acid preparation will contain white vaseline and 0.2% sodium hyaluronate in a 30 g container. The preparation will be applied for five days, locally on the nipple skin area after every second breastfeeding session and at least four times in 24 hours, alternating it with breast milk. The hyaluronic acid preparation will be distributed in the same packaging as the neutral agent used by the control group. The control group participants will apply the neutral agent containing only white vaseline for five days after every second breastfeeding session and at least four times in 24 hours, alternating it with breast milk. All mothers will be advised to wash the nipple skin with water before the next breastfeed.

The participants will be examined four times during their first postpartum month in the Breastfeeding Support Unit of the Health Centre 'Dom zdravlja'. The first check-up will occur 72 to 120 hours postpartum when the participants will be introduced to the study, provide consent for participation in the study, and, according to the allocator's instructions, will receive the preparation to treat the damaged nipple skin. Then, the researcher will advise the participants on how to position their babies during breastfeeding and correct possible irregularities.

The next check-up will occur at the Breastfeeding Support Unit on the seventh postpartum day when the condition of the damaged skin will be evaluated. The other check-ups will occur on the 10th and 30th postpartum days in the Breastfeeding Support Unit. During every checkup, the condition of the damaged nipple skin will be evaluated, participants will estimate the soreness on a visual analogue scale, and the mother's satisfaction with the treatment method will be assessed. During every visit, the baby's diet will be checked and noted, and possible side effects in the mother and child will be recorded.

Nipple healing will be measured using the Nipple Trauma Score (NTS), and the measurement will be done by the lead researcher. During the nipple skin checkup, the following NTS interpretation will be applied: 0) no macroscopically visible skin changes; 1) erythema or edema or combination of both; 2) superficial damage with or without scab formation of less than 25% of the nipple surface; 3) superficial damage with or without scab formation of more than 25% of the nipple surface; 4) partial-thickness wound with or without scab formation of less than 25% of the nipple surface; 5) partial-thickness wound with or without scab formation of more than 25% of the nipple surface.

Nipple pain will be estimated using an adapted visual analogue scale (VAS). The pain scale is marked by numbers 0 to 10, where 0 means no pain, and 10 is the highest pain imaginable. The mother will decide on the VAS scale, which measure best fits her pain: 0) no pain, feeling that the child is moving my breast; 1-2) minimal discomfort and pain; 3-5) moderate pain; 6-8) severe pain; 9-10) the severest pain I can imagine.

The mother's satisfaction with the applied preparation will be measured using a Likert scale. The mother will choose one of the given answers: 1- Very dissatisfied; 2 - Dissatisfied; 3 - Neutral/ don't have an opinion; 4 - Satisfied; and 5 - Very satisfied.

During Breastfeeding Support Unit visits, mothers will be asked whether they have noticed any side effects in either themselves or their child. In addition, infant feeding will be monitored, specifically if breastfeeding is exclusive during the first month. World Health Organisation (WHO) definitions will be used, according to which exclusive breastfeeding is defined as feeding the child with breast milk only, without any other fluids or food, besides minerals and vitamins.

The researcher aims to find the middle effect in the difference of numerical variables between the participants in the two independent groups, with a 0.05 level of significance and 0.08 statistical power; hence, the minimal sample needed is 64 participants per group or 128 participants in total. Assuming a 20% loss of participation within the study group, the expected sample is 160 participants to detect a statistically significant difference.

This study will use rigorous scientific procedures to investigate whether hyaluronic acid is more efficient in treating nipple skin damage in breastfeeding mothers than a neutral agent. If the intervention proves to be effective, i.e. if there is faster healing of the damaged nipple skin and a reduction in pain, it may be a potential way of easing breastfeeding difficulties of mothers at the beginning of the breastfeeding period, which might lead to a more significant percentage of breastfed children which will benefit the whole of society.

Being tested
Treatment of damaged nipple skin: Preparation with hyaluronic acid, Treatment of damaged nipple skin: Neutral preparation without hyaluronic acid
Keywords
hyaluronic acid, cracked nipple, breastfeeding
Medical subject headings
Breast Feeding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Treatment of damaged nipple skin: Preparation with hyaluronic acidDrug

    The active preparation will be applied for five days, locally on the damaged nipple skin after every second breastfeeding session, and at least four times in 24 hours, alternating it with breast milk.

  • Treatment of damaged nipple skin: Neutral preparation without hyaluronic acidDrug

    The neutral preparation, containing only white vaseline, will be applied for five days, locally on the damaged nipple skin after every second breastfeeding session, and at least four times in 24 hours, alternating it with breast milk.

Study groups in NCT05591651
Study groupRoleWhat they receive
Preparation with hyaluronic acidExperimentalTreatment of damaged nipple skin: Preparation with hyaluronic acid. The hyaluronic acid preparation will contain white vaseline and 0.2% sodium hyaluronate in a 30 g container.
Receives: Drug: Treatment of damaged nipple skin: Preparation with hyaluronic acid
Neutral Preparation without hyaluronic acidExperimentalTreatment of damaged nipple skin: Neutral preparation without hyaluronic acid. The neutral preparation will contain white vaseline only, in a 30 g container, and wiil have the same appearance and fragrance as the active preparation.
Receives: Drug: Treatment of damaged nipple skin: Neutral preparation without hyaluronic acid

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Healing of damaged nipples

    Nipple healing will be measured using the Nipple Trauma Score (NTS). Measurements will be performed by the lead researcher using the following scale: 0) no macroscopically visible skin changes; 1) erythema or edema or combination of both; 2) superficial damage with or without scab formation of less than 25% of the nipple surface; 3) superficial damage with or without scab formation of more than 25% of the nipple surface; 4) partial-thickness wound with or without scab formation of less than 25% of the nipple surface; 5) partial-thickness wound with or without scab formation of more than 25% of the nipple surface.

    Measured: 30 days

  2. Level of nipple pain

    Nipple pain will be estimated using an adapted VAS.The pain scale is marked by numbers 0 to 10, where 0 means no pain, and 10 is the highest pain imaginable. The mother will decide on the VAS scale, which measure best fits her pain: 0) no pain, feeling that the child is moving my breast; 1-2) minimal discomfort and pain; 3-5) moderate pain; 6-8) severe pain; 9-10) the severest pain I can imagine.

    Measured: 30 days

Secondary outcomes (3)
  1. Mother's satisfaction with allocated treatment

    The mother's satisfaction with the applied preparation will be measured using a Likert scale. The mother will be able to choose one of the following options: 1- Very dissatisfied; 2 - Dissatisfied; 3 - Neutral/ don't have an opinion; 4 - Satisfied; and 5 - Very satisfied.

    Measured: 30 days

  2. Exclusive breastfeeding rates at days 3, 7, 10, and 30 postpartum.

    During the Breastfeeding Support Unit visits, mothers wiil be asked by the lead researcher how their newborn was fed in the previous 24h, and since the last visit. WHO breastfeeding definitions wiil be used, according to which exclusive breastfeeding is defined as receiving only human milk, without any other fluids or food, apart from minerals and vitamins.

    Measured: 30 days

  3. Side effects in mother and child

    During Breastfeeding Support Unit visits, mothers will be asked whether they have noticed any side effects on themselves or on their infants.

    Measured: 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Oct 2022
  2. Study start9 Jan 2023
  3. Primary completionDec 2025 (estimated)
  4. Study completionFeb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
160 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05591651
Sponsor's protocol ID
123456
Status last verified
Jul 2024
First submitted
13 Oct 2022
Last updated
31 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Tait P. Nipple pain in breastfeeding women: causes, treatment, and prevention strategies. J Midwifery Womens Health. 2000 May-Jun;45(3):212-5. doi: 10.1016/s1526-9523(00)00011-8.

    PubMed 10907330
  • Abou-Dakn M, Fluhr JW, Gensch M, Wockel A. Positive effect of HPA lanolin versus expressed breastmilk on painful and damaged nipples during lactation. Skin Pharmacol Physiol. 2011;24(1):27-35. doi: 10.1159/000318228. Epub 2010 Aug 18.

    PubMed 20720454
  • Shaharudin A, Aziz Z. Effectiveness of hyaluronic acid and its derivatives on chronic wounds: a systematic review. J Wound Care. 2016 Oct 2;25(10):585-592. doi: 10.12968/jowc.2016.25.10.585.

    PubMed 27681589
  • Torretta S, Marchisio P, Rinaldi V, Carioli D, Nazzari E, Pignataro L. Endoscopic and clinical benefits of hyaluronic acid in children with chronic adenoiditis and middle ear disease. Eur Arch Otorhinolaryngol. 2017 Mar;274(3):1423-1429. doi: 10.1007/s00405-016-4327-4. Epub 2016 Oct 1.

    PubMed 27695944

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Treatment of damaged nipple skin: Preparation with hyaluronic acid and Treatment of damaged nipple skin: Neutral preparation without hyaluronic acid in people with Cracked Nipple and Breastfeeding, run by Specijalisticka Pedijatrijska Ordinacija prim.mr.sc. Maja Stimac, Specijalist Pedijatrije Sspecijalnosti Neonatologije at 1 site in Croatia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 31 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Croatia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Maja Štimac, MD; Mr.sc. (+385 98 799 188, maja@stimac.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Healing of damaged nipples (time frame: 30 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05591651, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in